Purpose To investigate the value of radiomics in predicting lymphovascular invasion (LVI) status of rectal cancer based on MRI. Materials and methods The retrospective study included 188 patients based on MRI with histologically confirmed rectal cancer and evaluated LVI status. Clinical factors and image data were collected, and radiomics features were extracted from multi-region (tumor and mesorectum) and single region (tumor), respectively, on T2WI and DWI. Spearman correlation analysis and the LASSO algorithm were used for radiomic feature extraction and selection; preliminarily selection of an optimal classifier by the results of the fivefold cross-validation performance in the six preselected specific machine learning classifier. Multi-regional and single-regional predictive models were both built and evaluated by calculating the area under the ROC curve (AUC) and corresponding accuracy, specificity, sensitivity, etc.
Introduction
Colorectal cancer (CRC) is the third most common malignant tumor in the world [1, 2] , and about one-third to 44% of CRC are occurred in the rectum [3] . The National Comprehensive Cancer Network (NCCN) Guidelines consider lymphovascular invasion (LVI), which is defined as the presence of tumor cells in the lymphatic vessels or blood vessels or both, as a significant negative factor in treatment options and prognostication in rectal cancer [4, 5] . Several investigations have revealed that patients with LVI may associate with lymph-node metastasis and benefit from adjuvant systemic therapy [6] [7] [8] [9] . Hence, it becomes increasingly important to evaluate LVI status preoperatively, so that patients with LVI might benefit from radical surgery and adjuvant treatments [4, 6, 10, 11] .
Currently, the LVI status is evaluated by histopathology after resection, which provides no accuracy preoperative 1 3 evaluation to a treatment option. The biopsy may provide the LVI status before surgery; however, the limited specimen fails to provide the information of the whole tumor [12, 13] . In addition to histopathology, rectal magnetic resonance imaging (MRI) is also an important means in tumor evaluation, which is noninvasively [3, 4, 14] . Previous studies on rectal MRI have demonstrated that the diagnostic performance of extramural venous invasion (EMVI) by MRI was good [15, 16] . However, the intramural blood vessels and lymphatic vessel invasion status, which are parts of the LVI, are failed to evaluate by MRI [17, 18] . Therefore, is there a way to accurately evaluate the LVI status in rectal cancer before treatment?
Radiomics is an emerging method for extracting quantitative features from medical imaging and assisting clinical decision to improve diagnostic, prognostic, and predictive accuracy [13, [19] [20] [21] . The central hypothesis that drives the development of radiomics is based on the tumor microenvironment description, which helps to assess the biological characteristics of the tumor [12, 19] . Rectal MRI is essential for pre-and post-treatment assessment of rectal cancer, as it provides anatomic structures and their relationship with the tumor with a high-spatial resolution [22, 23] . Rectal MRIbased radiomics have been used for treatment response [24] , lymph-node metastasis [25] , and prognostic evaluation [26] . However, MRI-based radiomics for LVI prediction remains underinvestigated in rectal cancer.
Therefore, the aim of this study was to develop a radiomics model for prediction of lymphovascular invasion in rectal cancer based on MRI.
Materials and methods

Patients
This study was approved by the ethics committee of The First Hospital of Jilin University, and the informed consent requirement was waived. We retrospectively evaluated patients with rectal cancer in our hospital between January 2016 and December 2018. Inclusion criteria were as follows (a) histologically confirmed rectal adenocarcinoma; (b) rectal MRI were performed before surgery within 2 weeks; (c) LVI were assessed by histopathology after resection. The exclusion criteria included a history of (a) preoperative chemoradiotherapy (CRT), radiotherapy, chemotherapy, or distant metastases, considering that the preoperative treatment maybe changed the LVI status; (b) poor MRI quality; (c) lack of clinic information, such as pretreatment carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9(CA19-9). Finally, we enrolled a total of 188 patients, 80 LVI +, and 108 LVI −. We randomly divide patients into training and testing cohorts in a 2:1 ratio.
Clinicopathologic data, including age, gender, the level of carcinoembryonic antigen (CEA), and carbohydrate antigen19-9 (CA 19-9), were derived from medical records. Laboratory analysis of CEA and CA19-9 was tested within 1 week before surgery. The threshold value for the CEA level was ≤ 5 ng/mL and >5 ng/mL, and the threshold value for the CA19-9 level was ≤ 39U/mL and >39U/mL, according to the normal range used in clinics.
Measurement of conventional radiology evaluation indicators: including the location of primary tumor, lesion involvement length, tumor thickness (measured on oblique axis T2WI), extramural depth of invasion (measured on oblique axis T2WI), mesorectal fascia (MRF, > 1 mm diagnostic negative, ≤ 1 mm positive), and maximum lymphnode short diameter (measured on-axis T2WI).
The data enrolled flowchart of the study is shown in Fig. 1 .
MRI data acquisition
The enrolled rectal MRIs were all performed on the same MR scanner (3.0T, Philips Ingenia, The Netherlands). And glycerine enema was required for rectal cleansing before scanning. To reduce abdomen motility, 20 mg of anisodamine was injected intramuscularly 30 min before MRI scanning. All patients underwent a rectal MRI protocol including sagittal, axial, oblique axial, and coronal T2-weighted images and DWI. High-resolution T2WI images were obtained using turbo spin-echo with a repetition time (TR) = 3500 ms, echo time (TE) = 100 ms, the field of view (FOV) = 180 × 180 mm, echo train length = 29, matrix = 288 × 256, thickness = 3.0 mm, and gap = 0.3 mm. DWI images were obtained with 2 b factors (0 and 1000 s/mm 2 ), and TR = 2800 ms, TE = 70 ms, FOV = 340 × 340 mm, matrix = 256 × 256, thickness = 4.0 mm, and gap = 1.0 mm. All MRI images were retrieved from the picture archiving and communication system (PACS) for tumor masking and radiomic feature extraction.
Tumor masking
Two radiologists (Dr. Fu and Dr. Liu with 8 and 3 years of experience in rectal cancer radiology diagnosis, respectively) who blinded to the histopathology results segmented the volumes of interest (VOIs) on high-spatialresolution T2WI and DWI via IntelliSpace Discovery (Philips, Best, The Netherlands). The volumes of interest (VOIs) were defined as follows: (a) the volumes of the whole primary tumor and excluding the intestinal lumen, which was manually drawn on each slice based on T2WI (slightly high signal) and DWI (high signal, b value of 1000 s/mm 2 ), which were drawn along the contour of the tumor; (b) the volume of the mesorectal region on unfat suppressed T2WI, which was between the MRF (the thinlow-signal intensity surrounding the mesorectum) and the outer edge of the tumor and rectal wall. The schematic diagram of the tumor and mesorectal region segmentation is shown in Fig. 2 .
Radiomic feature extraction and selection
We have used three VOIs in radiomic feature calculation. The radiomic feature was analyzed by Philips Radiomics Tool (Philips Healthcare, China, the core feature calculation is based on pyRadiomics [27] ). The extracted features are shown in Table 1 .
First, at the feature normalization step, we used the Min-Max scaling algorithm (Eq. 1):
Next, a Spearman correlation analysis of radiomic feature and the label were done. Features with the coefficient lower than absolute value 0.2 or the p value greater than 0.05 were removed accordingly because of the low correlation between these radiomic features and pathological labels.
Finally, at the dimensionality reduction step, least absolute shrinkage and selection operator (LASSO) algorithm [28] were used.
Radiomic model construction and evaluation
At the model construction and evaluation step, six linear classification algorithms were investigated, including Passive Aggressive Classifier, Perceptron, Ridge Classifier, SGD Classifier, Logistic Regression, and Linear Support Vector Classifier for training and prediction. First, in the model training stage, we used fivefold cross validation to evaluate the performance of six specific machine learning classifiers in the training cohort with 'accuracy' as the optimization metric, preliminarily selected the prediction model with the best prediction performance, and then evaluated the model in the training and test cohorts with the area under the ROC curve (AUC), etc.
Statistical analysis
All statistical analyses were performed using SPSS 24.0 (IBM Corp). Chi-square test was used to compare the differences in categorical variables (gender, the location of primary tumor, the level of CEA and CA19-9, and MRF status), while an independent sample t test or Mann-Whitney U test, as appropriate, was used to compare the differences in continues variables (age, lesion involvement length, tumor thickness, and extramural depth of invasion).
Receiver-operating characteristic (ROC) curves were generated to assess the diagnostic performance of the radiomic models in predicting LVI status by calculating the area under the ROC curve (AUC) and corresponding accuracy, specificity, sensitivity, and so on were calculated.
The reported statistical significance levels are all twosided, with the statistical significance set at 0.05. 
Results
Clinical characteristics
In total, 188 patients were identified and comprise the study cohort: 128 males (68%) and 60 females (32%), the age ranged from 24 to 89 years, with an average of 59.61 ± 11.75 years old. The demographic statistics characteristics of patients in the training and testing cohorts are shown in Table 1 . As is shown in Table 2 , there were significant statistical differences in gender and maximum lymph-node short diameter in the training cohort between the LVI positive and negative groups (P < 0.05). No significant differences in LVI prevalence were found between the two cohorts (P = 0.952). Overall, 42.4% and 42.9% of cases were LVI positive in the training and testing cohorts, respectively.
Radiomic feature extraction and selection
For each VOI, a total of 1653 three-dimensional (3D)-based radiomic features were extracted. These radiomic features quantified tumor characteristics using tumor size and shape, intensity statistics, and texture. For each patient, we integrated all of the 4959 radiomic features from three VOIs together.
We extracted radiomic features from multi-region (tumor and mesorectum) and single region (tumor), respectively, to investigate whether multi-regional radiomic model could improve the predictive performance in LVI. After the Spearman correlation analysis and LASSO algorithm, 21 radiomic features were retained for constructing the multi-regional radiomic model, including 2 clinical features (the location of primary tumor and maximum lymph-node short diameter), 10 radiomic features from mesorectum region, and 9 radiomic features from tumor region. In single-regional radiomic models, 10 radiomic features were retained (Table 3) .
Radiomic model construction and evaluation
We constructed multi-regional and single-regional radiomic models, and then compared their predictive performance. In the model training stage, we use the results of fivefold cross validation as the performance of a specific machine learning classifier. Ridge Classifier used in the feature extraction of Table 3 Feature coefficients of trained model multi-region and linear SVC used in the feature extraction of single region were found to produce the most accurate model on fivefold cross-validation data set, respectively (Fig. 3 ). In this linear models, the coefficients of each radiomic features are shown in Table 4 . As is shown in Fig. 4 , in the predictive multi-regional radiomic model, the mean AUC of the ROC curves of fivefold validation is 0.82; the AUC of training data sets and testing data sets is 0.87 and 0.74, respectively. In the predictive single-regional radiomic model, the mean AUC of the ROC curves of fivefold validation is 0.79; the AUC of training data sets and testing data sets is 0.81 and 0.72, respectively. For more performance index, please see Table 4 .
The AUC, accuracy, F1, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the multi-regional model is better than that of the singleregional model, except PPV in testing data sets.
Discussion
This retrospective study investigated a radiomic model based on MRI for the preoperative prediction of LVI status in patients with rectal cancer. We constructed and compared the single and multi-regional radiomic models for discriminate LVI invasion of rectal cancer patients. Our results suggest that MRI radiomic signature is significantly correlated with LVI. The multi-regional radiomic model was performed better than that of the single-regional model in preoperative prediction of LVI, with acceptable accuracy.
LVI is regarded as an important negative factor in treatment options and prognostication in rectal cancer from multiple statistically published trials. The previous study which was reported by Liu et al. found that the DCE-MRIbased radiomic features and LVI status were correlated in breast cancer, and indicated that the radiomic features were effective in predicting the LVI status of patients with invasive breast cancer before surgery [29] . However, it is still a challenge for LVI preoperative prediction in rectal cancer. In the clinic, rectal MRI was suggested to reflect EMVI in rectal cancer, which is only one part of LVI [15] [16] [17] [18] . Kim Y et al., who have investigated the visually assessed features, considered that the LVI presents when the mesorectal perivascular infiltrative signal was visible on pelvic MR imaging, and the sensitivity of MR-reported LVI status was 68.2% [30] . While the radiomic model in our study showed a better predictive performance than MRI-reported LVI status by Kim. The better performance in our research might be due to that the radiomic features which was derived from multi-regional VOIs in multiparametric MR images could provide comprehensive information on LVI status, including intramural, extramural blood vessels, and lymphatic vessels in rectal cancer.
Previous studies showed multi-regional MRI radiomics allowing for a more comprehensive characterization of the tumor heterogeneity. This may offer potential to improve the prediction performance [31, 32] . LVI, which is defined as the presence of tumor cells in the lymphatic vessels or blood vessels or both, include intramural, extramural blood vessels, and lymphatic vessels. In addition to the region of the tumor, the surrounding mesorectal tissues may also exhibit abnormal microscopic changes in the microvascular and lymphatic networks, extracellular matrix, and interstitial pressure, which cannot be ignored [33, 34] . Hence, we investigated whether multi-regional radiomics, including both tumor and mesorectum, could provide more features to discriminate LVI positive from LVI-negative lesions. When the current multi-regional radiomics signature was introduced into the prediction model, the performance improved than that of the single-regional model [34] . This suggests that the multiregional radiomic signature could enhance the prediction of LVI in rectal cancer patients. In addition, our study used [35, 36] . How to select a modeling method is important for the performance of the radiomic model. Hence, a variety of machine learning methods should be used and the implementation should be fully documented [13] , and then compare the performance of different algorithms. In our study, Ridge Classifier used in the features extraction of multiregion and linear SVC used in the feature extraction of single region were found to produce the most accurate model on fivefold cross-validation data set, respectively, can predict the LVI and maybe assist clinical decision-making.
There are some limitations to this study. First, the sample was divided into training and testing cohorts, but lacked of external testing validation. It likely led to overfitting. And all the enrolled MRIs were performed on the same MR scanner, which may also reduce the robustness of the prediction models. In the future, the study cohort should mixed different MRI scanners' data sets to enhance robustness. Moreover, a multicenter study with a larger sample size and external validation is warranted. Second, the study did not evaluate T1 W and enhanced MR images, and only the VOIs of T2WI and DWI were calculated. However, in clinic, the T2WI and Fig. 4 ROC curves of radiomic models: a ROC of multi-regional model in fivefold cross validation; b ROCs of multi-regional model in training and testing data sets; c ROC of single-regional model in fivefold cross validation; d ROCs of single-regional model in training and testing data sets DWI play vital role in tumor evaluation, which have a proven high diagnostic accuracy [23, 37] . Third, LVI status was only classified as positive or negative in this study. LVI status was further categorized into four grades based on the number of lymphovascular structures invaded, according to Jass classification (expanding vs infiltrative) [17, 18] . Further study should investigate the relationship between radiomic feature scores with grades of LVI. Finally, this research was a retrospective study. Therefore, there is an inevitable selectivity bias. In the future, we will design a prospective study of radiomic data related to rectal cancer.
In conclusion, the radiomic model which we developed demonstrates that multi-regional and multiparametric radiomic features based on MRI are useful tools for preoperatively predicting lymphovascular invasion in patients with rectal cancer.
